Literature DB >> 32458466

Clinical characteristics of hidradenitis suppurativa patients in Okinawa, Japan: Differences between East Asia and Western countries.

Takuya Omine1, Takuya Miyagi1, Kentaro Hayashi1, Sayaka Yamaguchi1, Kenzo Takahashi1.   

Abstract

Hidradenitis suppurativa (HS) is a long-term inflammatory follicular disease. In Western countries, the prevalence of HS has been estimated to be 0.1-4% in the general population. In Okinawa Prefecture, the southernmost area of Japan, HS is more frequent than in other parts of Japan. The aim of this study is to elucidate the epidemiological features of HS patients in Okinawa, Japan, to determine the factors correlated with severity and to compare characteristics of HS patients in East Asia and Western countries. This study was a retrospective, single-center, case series study. Data of patients with HS diagnosed at the University of the Ryukyus Hospital from April 2010 to March 2019 were collected and compared with data of previous studies performed in Japan, Korea, France and the USA. There were 42 male and 16 female HS patients (age range, 15-76 years). The median modified Sartorius score was 49 (interquartile range, 87.3). A multivariate analysis indicated that disease duration was associated with the modified Sartorius score. The ratio of serum C-reactive protein to albumin was significantly correlated with disease severity (rs  = 0.64, P < 0.001). Overall, in East Asia, HS was more common in males, and very few patients had a family history of HS (1.7% vs 29.1%, P < 0.001) compared with Western countries. This study revealed the characteristics of HS patients in Okinawa and elucidated the differences between the epidemiology of HS in Western countries and East Asia. In addition, we found out factors that correlated with disease severity such as disease duration and serum C-reactive protein to albumin ratio.
© 2020 Japanese Dermatological Association.

Entities:  

Keywords:  Asian; C-reactive protein to albumin ratio; Okinawa; disease duration; hidradenitis suppurativa

Mesh:

Year:  2020        PMID: 32458466     DOI: 10.1111/1346-8138.15411

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  Mediterranean diet, lifestyle and quality of life in Sardinian patients affected with Hidradenitis suppurativa.

Authors:  Fernanda Velluzzi; Jasmine Anedda; Silvia Pisanu; Massimo Dell'Antonia; Andrea Deledda; Alessandro Boi; Caterina Ferreli; Laura Atzori
Journal:  J Public Health Res       Date:  2021-11-29

2.  Massive squamous cell carcinoma arising from hidradenitis suppurativa with marked hypercalcemia and neutrophilia.

Authors:  Haruka Uehara; Sayaka Yamaguchi; Kyoko Fukai; Takuya Omine; Takuya Miyagi; Kenzo Takahashi
Journal:  JAAD Case Rep       Date:  2022-08-20

3.  Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan.

Authors:  Nobukazu Hayashi; Koremasa Hayama; Kenzo Takahashi; Ichiro Kurokawa; Masateru Okazaki; Tomoko Kashiwagi; Eri Iwashita; Tadashi Terui
Journal:  J Dermatol       Date:  2022-01-17       Impact factor: 3.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.